Gr
Grünenthal
Aachen DEFounded 19464,500 employees
Private CappharmaPrivateCNS
Platform: Pain Specialty
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Darasertib | GR-600 | Phase 1 | 2 | Nectin-4 | MigraineMDD | ||
| GR-6650 | GR-6650 | NDA/BLA | 2 | PLK4 | Parkinson'sCKD | ||
| GR-8075 | GR-8075 | Preclinical | 2 | KRASG12C | RettHCC | ||
| Surabrutinib | GR-9592 | Phase 2 | 2 | RET | HCCDLBCL |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)